Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 2
1985 1
1987 1
1995 1
1996 1
1997 2
1998 2
1999 1
2000 1
2001 2
2002 2
2003 1
2005 1
2006 5
2007 2
2008 3
2009 1
2010 1
2011 3
2012 1
2013 3
2014 4
2015 5
2016 10
2017 5
2018 10
2019 9
2020 7
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 32245895

76 results

Results by year

Filters applied: . Clear all
Page 1
Lesion Detection and Administered Activity.
McCready VR, Dizdarevic S, Beyer T. McCready VR, et al. J Nucl Med. 2020 Sep;61(9):1406-1410. doi: 10.2967/jnumed.120.244020. Epub 2020 Apr 3. J Nucl Med. 2020. PMID: 32245895 Free article. No abstract available.
Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine.
Knopp MV, Bourne MW, Sardanelli F, Wasser MN, Bonomo L, Boetes C, Müller-Schimpfle M, Hall-Craggs MA, Hamm B, Orlacchio A, Bartolozzi C, Kessler M, Fischer U, Schneider G, Oudkerk M, Teh WL, Gehl HB, Salerio I, Pirovano G, La Noce A, Kirchin MA, Spinazzi A. Knopp MV, et al. AJR Am J Roentgenol. 2003 Sep;181(3):663-76. doi: 10.2214/ajr.181.3.1810663. AJR Am J Roentgenol. 2003. PMID: 12933457 Clinical Trial.
Breast lesion detection and characterization with contrast-enhanced magnetic resonance imaging: Prospective randomized intraindividual comparison of gadoterate meglumine (0.15 mmol/kg) and gadobenate dimeglumine (0.075 mmol/kg) at 3T.
Clauser P, Helbich TH, Kapetas P, Pinker K, Bernathova M, Woitek R, Kaneider A, Baltzer PAT. Clauser P, et al. J Magn Reson Imaging. 2019 Apr;49(4):1157-1165. doi: 10.1002/jmri.26335. Epub 2018 Dec 15. J Magn Reson Imaging. 2019. PMID: 30552829 Free PMC article. Clinical Trial.
76 results